Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
9.25
|
19.20
|
14.02
|
13.62
|
14.05
|
13.62
|
|
|
48 949.37
|
96.00
|
13.38
|
16.35
|
13.91
|
13.91
|
14.03
|
13.91
|
|
|
34 912.95
|
83.00
|
13.30
|
15.41
|
12.99
|
12.99
|
14.19
|
13.96
|
|
|
41 700.13
|
78.00
|
12.51
|
13.26
|
13.59
|
12.94
|
13.61
|
13.05
|
|
|
43 951.18
|
157.00
|
11.20
|
13.77
|
13.12
|
13.12
|
13.90
|
13.50
|
|
|
89 888.64
|
203.00
|
12.40
|
14.35
|
13.04
|
12.97
|
13.47
|
13.36
|
|
|
42 890.98
|
108.00
|
12.31
|
13.30
|
13.15
|
12.96
|
13.33
|
12.96
|
|
|
34 039.37
|
191.00
|
12.30
|
13.82
|
14.04
|
13.54
|
14.12
|
13.54
|
|
|
29 974.22
|
74.00
|
12.98
|
14.36
|
13.93
|
13.74
|
14.21
|
14.02
|
|
|
54 453.52
|
118.00
|
13.54
|
14.33
|
13.80
|
13.80
|
14.02
|
13.975
|
|
|
73 166.17
|
200.00
|
NeuroPace, Inc. operates as a commercial-stage medical device company. The Company designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders with responsive stimulation. NeuroPace serves patients worldwide.